ID: ALA3125977

Max Phase: Preclinical

Molecular Formula: C17H12F2N2O4

Molecular Weight: 346.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCc1ccc(F)c(F)c1)c1cc2cccc(O)c2n(O)c1=O

Standard InChI:  InChI=1S/C17H12F2N2O4/c18-12-5-4-9(6-13(12)19)8-20-16(23)11-7-10-2-1-3-14(22)15(10)21(25)17(11)24/h1-7,22,25H,8H2,(H,20,23)

Standard InChI Key:  RTZZCXRVKNMTNQ-UHFFFAOYSA-N

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.29Molecular Weight (Monoisotopic): 346.0765AlogP: 2.15#Rotatable Bonds: 3
Polar Surface Area: 91.56Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.90CX Basic pKa: CX LogP: 1.94CX LogD: 1.82
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.63Np Likeness Score: -1.22

References

1. Zhao XZ, Smith SJ, Métifiot M, Johnson BC, Marchand C, Pommier Y, Hughes SH, Burke TR..  (2014)  Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.,  57  (4): [PMID:24471816] [10.1021/jm401902n]
2. Wang Y, Gu SX, He Q, Fan R..  (2021)  Advances in the development of HIV integrase strand transfer inhibitors.,  225  [PMID:34425310] [10.1016/j.ejmech.2021.113787]

Source